Rasha et al. [155] found that DVL2 controls cancer cell proliferation and T cell-mediated immunity in HER2-positive breast cancer through the DVL2 loss of function studies, implying the potential immune regulatory role of DVL2 proteins. This evidence concerns the gene DVL2 and breast carcinoma.